CRVL (CRVL) Stock Analysis
Verdict: HOLD
CareMC Guidewire integration drives operational moat, but heavy insider selling and a 33x P/E cap 90-day upside.
Investment score: 57/100
Is CRVL Stock Worth Reviewing? AI Model Thesis
The model recommends HOLD on CorVel Corp (CRVL) with a 90-day investment score of 57/100. Excellent balance sheet metrics and workflow software moat are offset by heavy insider selling and an elevated 33.04x TTM P/E valuation.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| BLLN | 179.97 | 10.74 | 14.37 | 105.64 | — | 0.08 |
| RDNT | -263.83 | 4.99 | 2.44 | 20.71 | — | -0.01 |
| LFST | 90.75 | 3.07 | 2.89 | 34.61 | — | 0.03 |
| OPCH | 17.21 | 2.81 | 0.60 | 10.84 | — | 0.04 |
| GRDN | 39.70 | 10.75 | 1.80 | 22.67 | — | 0.05 |
Should You Buy or Sell CRVL Stock? Model Reasoning
CorVel exhibits premium balance sheet strength with $205M in net cash and high capital efficiency (ROE 29.93%). However, valuation is rich at 33.04x P/E (vs peer OPCH at 17.21x), and persistent insider selling (18 sales, 0 buys) creates immediate overhead supply near 79.69 USD resistance.
CRVL Fair Value & Price Target — AI Valuation
- Model Assumptions: ["Baseline revenue CAGR of 7.0% over 5 years (matching FY2026 actual growth of 7.09%).","Operating margin remains stable around 15.0%-15.5% with capex averaging $40M annually.","Discount rate of 10.0% with a 2.5% terminal growth rate and $4.00/share net cash credit."]
CRVL Risk & Opportunity Analysis
Key Investment Risks
- Persistent insider distribution signaling potential valuation ceiling. — Corstar Holdings Inc sold over 225k shares in Sept 2026 alone around $68.75-$70.16; continued selling caps near-term upside.
- Valuation multiple compression risk given peer median P/E divergence. — If EPS growth decelerates below 10%, the current 33.04x TTM P/E could compress toward peer median (22x), risking a ~30% re-rating down toward FMP DCF benchmark of 34.75 USD.
- Macroeconomic slowdown impacting workers' compensation claim volume. — Lower employment rates or declining workers' comp claim volumes would directly reduce transaction fee volumes in Core CareMC operations.
- Rising capital expenditures compressing operating margin expansion. — CapEx increased from $35.76M in FY2025 to $45.36M in FY2026; uncurbed spending on software R&D could press operating margin below 15.0%.
Growth Opportunities & Upside Drivers
- Guidewire ClaimCenter ecosystem integration accelerates workflow embedding. — Direct availability inside Guidewire workflows on Sept 22, 2026 reduces friction for prospective insurer clients, driving multi-year ARR expansion.
- Robust net cash balance provides M&A and tech investment flexibility. — Net cash of $205M ($233.1M cash vs $28.1M debt) allows continuous AI R&D funding without external equity or debt dilution.
- Consistent operating leverage driving FY2026 earnings expansion. — Operating income rose from $120.8M in FY2025 to $143.1M in FY2026, pushing net margins to 11.72%.
- Expanding FCF generation supporting buybacks or strategic deployment. — FY2026 Free Cash Flow reached $110.28M (+20.4% YoY), providing a 3.0% FCF yield to support equity value.
CRVL Action Plan — Entry, Exit and Stop Loss from the Model View
moderate
aggressive
conservative
Frequently Asked Questions About CRVL (CRVL)
Is CRVL stock a good investment?
The cached TradeMates AI model rates CRVL as HOLD with an investment score of 57/100. The model recommends HOLD on CorVel Corp (CRVL) with a 90-day investment score of 57/100. Excellent balance sheet metrics and workflow software moat are offset by heavy insider selling and an elevated 33.04x TTM P/E valuation. This is algorithmic model output, not personal investment advice.
Does CRVL pay a dividend?
The cached stock data on this page does not show a positive dividend yield for CRVL. Dividend status can change, so verify the latest company filings before relying on income assumptions.
What does CRVL stock do?
Technology-enabled healthcare cost containment and managed care services for workers compensation, auto liability, and self-insured employers, generating recurring fee-for-service and bill-auditing revenue.
What is CRVL stock's price target?
This cached page does not contain a precise model fair value for CRVL.
Is CRVL stock a buy?
The TradeMates model verdict for CRVL is HOLD with an investment score of 57/100. Treat this as a model signal to review, not a personal buy recommendation.
Is CRVL a good dividend stock?
CRVL is not presented as a dividend idea on this cached TradeMates page because no positive dividend yield is available in the cached data.